Regulation of retinal dehydrogenases and retinoic acid synthesis by cholesterol metabolites
Regulation of retinal dehydrogenases and retinoic acid synthesis by cholesterol metabolites
复制标题
DOI:
10.1038/sj.emboj.7601181
复制
发表时间:
2006-07-12
期刊:
影响因子:
11.4
通讯作者:
Wei, Li-Na
中科院分区:
文献类型:
--
作者:
Huq, M. D. Mostaqul;Tsai, Nien-Pei;Wei, Li-Na
Retinoic acid (RA) constitutes the major active ingredient of vitamin A and is required for various biological processes. The tissue RA level is maintained through a cascade of metabolic reactions where retinal dehydrogenases (RALDHs) catalyze the terminal reaction of RA biosynthesis from retinal, a rate-limiting step. We showed that dietary supplement of cholesterol enhanced the expression of RALDH1 and 2 genes and the cellular RA content in vital organs such as brain, kidney, liver and heart. Consistently, the cholesterol-lowering agent (pravastatin sodium) downregulated the expression of RALDH1 and 2 genes in several organs especially the liver and in cultured liver cells. Further, cholesterol metabolites, predominantly the oxysterols, the natural ligands for liver X receptor (LXR), induced these genes via upregulation of sterol regulatory element binding protein-1c (SREBP-1c) that bound to the regulatory regions of these genes. Knockdown of LXRa/b or SREBP-1c downregulated the expression of RALDH genes, which could be rescued by re-expressing SREBP-1c, suggesting SREBP-1c as a direct positive regulator for these genes. This study uncovered a novel crosstalk between cholesterol and RA biosynthesis.